Liu Q, Hu M, Li S, Zhang X, Zhang R, Lyu H
Biomark Res. 2024; 12(1):152.
PMID: 39633507
PMC: 11616203.
DOI: 10.1186/s40364-024-00699-2.
Shikha D, Dalai R, Kumar S, Goswami C
J Membr Biol. 2024; 257(5-6):345-364.
PMID: 39150496
PMC: 11584472.
DOI: 10.1007/s00232-024-00319-y.
Weidner A, Roy A, Vann K, Walczyk A, Astapova O
Mol Hum Reprod. 2024; 30(5).
PMID: 38718206
PMC: 11136451.
DOI: 10.1093/molehr/gaae018.
Chen Z, Xie H, Liu J, Zhao J, Huang R, Xiang Y
Cancer Biol Ther. 2024; 25(1):2338955.
PMID: 38680092
PMC: 11062369.
DOI: 10.1080/15384047.2024.2338955.
Guerrero-Ochoa P, Rodriguez-Zapater S, Anel A, Esteban L, Camon-Fernandez A, Espilez-Ortiz R
Int J Mol Sci. 2024; 25(4).
PMID: 38396837
PMC: 10888820.
DOI: 10.3390/ijms25042152.
Intracellular Ca signalling: unexpected new roles for the usual suspect.
Moccia F, Fiorio Pla A, Lim D, Lodola F, Gerbino A
Front Physiol. 2023; 14:1210085.
PMID: 37576340
PMC: 10413985.
DOI: 10.3389/fphys.2023.1210085.
Visualization of the protein-protein interactions of hormone receptors in hormone-dependent cancer research.
Iwabuchi E, Miki Y, Suzuki T, Sasano H
Endocr Oncol. 2023; 2(1):R132-R142.
PMID: 37435453
PMC: 10259353.
DOI: 10.1530/EO-22-0059.
Diverse role of androgen action in human breast cancer.
Takagi K, Yamaguchi M, Miyashita M, Sasano H, Suzuki T
Endocr Oncol. 2023; 2(1):R102-R111.
PMID: 37435447
PMC: 10259322.
DOI: 10.1530/EO-22-0048.
Therapeutic potential of TRPM8 channels in cancer treatment.
Ochoa S, Casas Z, Albarracin S, Sutachan J, Torres Y
Front Pharmacol. 2023; 14:1098448.
PMID: 37033630
PMC: 10073478.
DOI: 10.3389/fphar.2023.1098448.
Regulation of ThermoTRP Channels by PIP2 and Cholesterol.
Rosenbaum T, Morales-Lazaro S
Adv Exp Med Biol. 2023; 1422:245-277.
PMID: 36988884
DOI: 10.1007/978-3-031-21547-6_9.
On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications.
Ciaglia T, Vestuto V, Bertamino A, Gonzalez-Muniz R, Gomez-Monterrey I
Front Oncol. 2023; 12:1065935.
PMID: 36844925
PMC: 9948629.
DOI: 10.3389/fonc.2022.1065935.
Global Trends and Hotspots of Transient Receptor Potential Melastatin 8 Research from 2002 to 2021: A Bibliometric Analysis.
Zhang Z, Kang L, Yan X, Leng Z, Fang K, Chen T
J Pain Res. 2022; 15:3881-3892.
PMID: 36536695
PMC: 9759117.
DOI: 10.2147/JPR.S393582.
TRPM8 as an Anti-Tumoral Target in Prostate Cancer Growth and Metastasis Dissemination.
Grolez G, Chinigo G, Barras A, Hammadi M, Noyer L, Kondratska K
Int J Mol Sci. 2022; 23(12).
PMID: 35743115
PMC: 9224463.
DOI: 10.3390/ijms23126672.
TRPM8-Rap1A Interaction Sites as Critical Determinants for Adhesion and Migration of Prostate and Other Epithelial Cancer Cells.
Chinigo G, Grolez G, Audero M, Bokhobza A, Bernardini M, Cicero J
Cancers (Basel). 2022; 14(9).
PMID: 35565390
PMC: 9102551.
DOI: 10.3390/cancers14092261.
Target Protein for Xklp2 Functions as Coactivator of Androgen Receptor and Promotes the Proliferation of Prostate Carcinoma Cells.
Sun B, Long Y, Xiao L, Wang J, Yi Q, Tong D
J Oncol. 2022; 2022:6085948.
PMID: 35444697
PMC: 9015851.
DOI: 10.1155/2022/6085948.
New Insights and Emerging Therapeutic Approaches in Prostate Cancer.
Licitra F, Giovannelli P, Di Donato M, Monaco A, Galasso G, Migliaccio A
Front Endocrinol (Lausanne). 2022; 13:840787.
PMID: 35222290
PMC: 8873523.
DOI: 10.3389/fendo.2022.840787.
Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmacological intervention.
Huang T, Zhou J, Wang J
Int J Biol Sci. 2022; 18(3):1065-1078.
PMID: 35173539
PMC: 8771838.
DOI: 10.7150/ijbs.68591.
Endocrine Disruptors and Prostate Cancer.
Corti M, Lorenzetti S, Ubaldi A, Zilli R, Marcoccia D
Int J Mol Sci. 2022; 23(3).
PMID: 35163140
PMC: 8835300.
DOI: 10.3390/ijms23031216.
Therapeutic potential of TRPM8 antagonists in prostate cancer.
Di Donato M, Ostacolo C, Giovannelli P, Di Sarno V, Monterrey I, Campiglia P
Sci Rep. 2021; 11(1):23232.
PMID: 34853378
PMC: 8636514.
DOI: 10.1038/s41598-021-02675-4.
TRP Channels in Brain Tumors.
Chinigo G, Castel H, Chever O, Gkika D
Front Cell Dev Biol. 2021; 9:617801.
PMID: 33928077
PMC: 8076903.
DOI: 10.3389/fcell.2021.617801.